Josh Zeidner, MD, Jon Serody, MD, and colleagues report clinical trial outcomes that benefited patients with resistant or relapsed acute myeloid leukemia.

William Kim, MD, and colleagues have published findings that adding the experimental drug entinostat to an immunotherapy-like treatment substantially boosted cancer remission in laboratory models.

UNC Lineberger faculty have held leadership and team membership roles with The Cancer Genome Atlas, which was launched in 2006.